Economic Evaluation of Enhanced Asthma Management: a Systematic Review

Overview

Journal Pharm Pract (Granada)

Date 2015 Jan 13

PMID 25580173

Citations 5

Authors

Yee V Yong

Asrul A Shafie

Affiliations

Soon will be listed here.

Abstract

Objectives: To evaluate and compare full economic evaluation studies on the cost-effectiveness of enhanced asthma management (either as an adjunct to usual care or alone) vs. usual care alone.

Methods: Online databases were searched for published journal articles in English language from year 1990 to 2012, using the search terms '"asthma" AND ("intervene" OR "manage") AND ("pharmacoeconomics" OR "economic evaluation" OR "cost effectiveness" OR "cost benefit" OR "cost utility")'. Hand search was done for local publishing. Only studies with full economic evaluation on enhanced management were included (cost consequences (CC), cost effectiveness (CE), cost benefit (CB), or cost utility (CU) analysis). Data were extracted and assessed for the quality of its economic evaluation design and evidence sources.

Results: A total of 49 studies were included. There were 3 types of intervention for enhanced asthma management: education, environmental control, and self-management. The most cost-effective enhanced management was a mixture of education and self-management by an integrated team of healthcare and allied healthcare professionals. In general, the studies had a fair quality of economic evaluation with a mean QHES score of 73.7 (SD=9.7), and had good quality of evidence sources.

Conclusion: Despite the overall fair quality of economic evaluations but good quality of evidence sources for all data components, this review showed that the delivered enhanced asthma managements, whether as single or mixed modes, were overall effective and cost-reducing. Whilst the availability and accessibility are an equally important factor to consider, the sustainability of the cost-effective management has to be further investigated using a longer time horizon especially for chronic diseases such as asthma.

Citing Articles

Deploying an asthma dashboard to support quality improvement across a nationally representative sentinel network of 7.6 million people in England.

Mukherjee M, Okusi C, Jamie G, Byford R, Ferreira F, Fletcher M NPJ Prim Care Respir Med. 2024; 34(1):18.

PMID: 38951547 PMC: 11217285. DOI: 10.1038/s41533-024-00377-8.

Using a dynamic adherence Markov model to assess the efficiency of Respiratory Medication Therapy Adherence Clinic (RMTAC) on asthma patients in Malaysia.

Yong Y, Shafie A Cost Eff Resour Alloc. 2018; 16:36.

PMID: 30377414 PMC: 6195711. DOI: 10.1186/s12962-018-0156-1.

Economic evidence for nonpharmacological asthma management interventions: A systematic review.

Crossman-Barnes C, Peel A, Fong-Soe-Khioe R, Sach T, Wilson A, Barton G Allergy. 2017; 73(6):1182-1195.

PMID: 29105788 PMC: 6033175. DOI: 10.1111/all.13337.

Impact of Adding a Decision Aid to Patient Education in Adults with Asthma: A Randomized Clinical Trial.

Gagne M, Legare F, Moisan J, Boulet L PLoS One. 2017; 12(1):e0170055.

PMID: 28107540 PMC: 5249233. DOI: 10.1371/journal.pone.0170055.

ECONOMIC EVALUATIONS OF INTERVENTIONS FOR TRANSTIBIAL AMPUTEES: A SCOPING REVIEW OF COMPARATIVE STUDIES.

Highsmith M, Kahle J, Lewandowski A, Klenow T, Orriola J, Miro R Technol Innov. 2017; 18(2-3):85-98.

PMID: 28066519 PMC: 5218541. DOI: 10.21300/18.2-3.2016.85.

References

Mehuys E, Van Bortel L, De Bolle L, Van Tongelen I, Annemans L, Remon J . Effectiveness of pharmacist intervention for asthma control improvement. Eur Respir J. 2007; 31(4):790-9. DOI: 10.1183/09031936.00112007. View

Wood M, Bolyard D . Making education count: the nurse's role in asthma education using a medical home model of care. J Pediatr Nurs. 2011; 26(6):552-8. DOI: 10.1016/j.pedn.2010.06.009. View

Lindberg M, Ahlner J, Ekstrom T, Jonsson D, Moller M . Asthma nurse practice improves outcomes and reduces costs in primary health care. Scand J Caring Sci. 2002; 16(1):73-8. DOI: 10.1046/j.1471-6712.2002.00054.x. View

Rossiter L, Small R, Shasky C, Bovbjerg V, Penberthy L, Okasha A . The impact of disease management on outcomes and cost of care: a study of low-income asthma patients. Inquiry. 2000; 37(2):188-202. View

Davis J, Robertson M, Ashe M, Liu-Ambrose T, Khan K, Marra C . Does a home-based strength and balance programme in people aged > or =80 years provide the best value for money to prevent falls? A systematic review of economic evaluations of falls prevention interventions. Br J Sports Med. 2010; 44(2):80-9. DOI: 10.1136/bjsm.2008.060988. View

Barnett S, Nurmagambetov T . Costs of asthma in the United States: 2002-2007. J Allergy Clin Immunol. 2011; 127(1):145-52. DOI: 10.1016/j.jaci.2010.10.020. View

Bousquet J, Clark T, Hurd S, Khaltaev N, Lenfant C, OByrne P . GINA guidelines on asthma and beyond. Allergy. 2007; 62(2):102-12. DOI: 10.1111/j.1398-9995.2006.01305.x. View

Almqvist C, Worm M, Leynaert B . Impact of gender on asthma in childhood and adolescence: a GA2LEN review. Allergy. 2007; 63(1):47-57. DOI: 10.1111/j.1398-9995.2007.01524.x. View

Woods E, Bhaumik U, Sommer S, Ziniel S, Kessler A, Chan E . Community asthma initiative: evaluation of a quality improvement program for comprehensive asthma care. Pediatrics. 2012; 129(3):465-72. DOI: 10.1542/peds.2010-3472. View

10.

McLean W, Gillis J, Waller R . The BC Community Pharmacy Asthma Study: A study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in British Columbia. Can Respir J. 2003; 10(4):195-202. DOI: 10.1155/2003/736042. View

11.

Runge C, Lecheler J, Horn M, Tews J, Schaefer M . Outcomes of a Web-based patient education program for asthmatic children and adolescents. Chest. 2006; 129(3):581-93. DOI: 10.1378/chest.129.3.581. View

12.

Shelledy D, Legrand T, Gardner D, Peters J . A randomized, controlled study to evaluate the role of an in-home asthma disease management program provided by respiratory therapists in improving outcomes and reducing the cost of care. J Asthma. 2009; 46(2):194-201. DOI: 10.1080/02770900802610068. View

13.

Tschopp J, Frey J, Janssens J, Burrus C, Garrone S, Pernet R . Asthma outpatient education by multiple implementation strategy. Outcome of a programme using a personal notebook. Respir Med. 2005; 99(3):355-62. DOI: 10.1016/j.rmed.2004.07.006. View

14.

Drummond M, Sculpher M . Common methodological flaws in economic evaluations. Med Care. 2005; 43(7 Suppl):5-14. DOI: 10.1097/01.mlr.0000170001.10393.b7. View

15.

Chan A, Wang H . Pharmacoeconomic assessment of clinical pharmacist interventions for patients with moderate to severe asthma in outpatient clinics : experience in taiwan. Clin Drug Investig. 2007; 24(10):603-9. DOI: 10.2165/00044011-200424100-00006. View

16.

Kauppinen R, Vilkka V, Sintonen H, Klaukka T, Tukiainen H . Long-term economic evaluation of intensive patient education during the first treatment year in newly diagnosed adult asthma. Respir Med. 2001; 95(1):56-63. DOI: 10.1053/rmed.2000.0971. View

17.

Masoli M, Fabian D, Holt S, Beasley R . The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004; 59(5):469-78. DOI: 10.1111/j.1398-9995.2004.00526.x. View

18.

Langer A . A framework for assessing Health Economic Evaluation (HEE) quality appraisal instruments. BMC Health Serv Res. 2012; 12:253. PMC: 3507835. DOI: 10.1186/1472-6963-12-253. View

19.

Levenson T, Grammer L, Yarnold P, Patterson R . Cost-effective management of malignant potentially fatal asthma. Allergy Asthma Proc. 1997; 18(2):73-8. DOI: 10.2500/108854197778605455. View

20.

Franco R, Santos A, do Nascimento H, Souza-Machado C, Ponte E, Souza-Machado A . Cost-effectiveness analysis of a state funded programme for control of severe asthma. BMC Public Health. 2007; 7:82. PMC: 1896159. DOI: 10.1186/1471-2458-7-82. View